Opus Genetics IRD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's common stock, par value (in dollars per share)?
- Opus Genetics (IRD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Opus Genetics's common stock, par value (in dollars per share) changed year-over-year?
- Opus Genetics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Opus Genetics's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Opus Genetics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.